Jonathan G. Braun, MD, PhD
No patient rating & comments.
Why?
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.
No patient rating & comments.
Why?
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.
Jonathan G. Braun, MD, PhD
No patient rating & comments.
Why?
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.
Jonathan G. Braun, MD, PhD
Languages
- English,
Gender
Male
Experience
41 Years
Experience
Research Areas
Education & Training
-
Brigham and Women's Hospital
Residency - Completed 1985
-
Whitehead Institute
Degrees - Completed 1985
-
Harvard Medical School
Medical School - Completed 1981
-
Harvard University
Degrees - Completed 1980
-
Stanford University
Degrees - Completed 1975
Achievements
-
6
Awards and Honors
-
6
Publications
Awards and Honors
- Sidney Truelove Lecture, International Organization for the Study of IBD (IOIBD)
- Charles M. Mansbach, II, MD, Memorial Lecture. American Gastroenterological Association
- Leukemia Society Scholar Award
- Modell Award, Crohn's and Colitis Foundation of America
- Fellow, American Association for the Advancement of Science
- Fellow, American Gastroenterological Association
Publications
- Chang YL, Rossetti M, Vlamakis H, Casero D, Sunga G, Harre N, Miller S, R Humphries, Stappenbeck T, Simpson KW, Sartor RB, Wu G, Lewis J, Bushman F, McGovern DPB, Salzman N, Borneman J, Xavier R, Huttenhower C, Braun J. A screen of Crohn's disease-associated microbial metabolites identifies a novel metabolic inhibitor of activated human T cells. Mucosal Immunol. 2018 Apr 25. doi: 10.1038/s41385-018-0022-7. [Epub ahead of print]
- Li D, Achkar JP, Haritunians T, Jacobs JP, Hui KY, D'Amato M, Brand S, Radford-Smith G, Halfvarson J, Niess JH, Kugathasan S, Büning C, Schumm LP, Klei L, Ananthakrishnan A, Aumais G, Baidoo L, Dubinsky M, Fiocchi C, Glas J, Milgrom R20, Proctor DD, Regueiro M, Simms LA, Stempak JM, Targan SR, Törkvist L, Sharma Y, Devlin B, Borneman J, Hakonarson H, Xavier RJ, Daly M, Brant SR, Rioux JD, Silverberg MS, Cho JH, Braun J, et al. A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition. Gastroenterology. 2016;151:724-732.
- Tong M, McHardy I, Ruegger P, Goudarzi M, Kashyap PC, Haritunians T, Li X, Graeber TG, Schwager E, Huttenhower C, Fornace AJ, Jr., Sonnenburg JL, McGovern DP, Borneman J, Braun J. Reprogramming gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism. ISME J. 2014;8:2193-2206
- Yamamoto ML, Maier I, Dang AT, Berry D, Liu J, Ruegger PM, Yang JI, Soto PA, Presley LL, Reliene R, Westbrook AM, Wei B, Loy A, Chang C, Braun J, Borneman J, Schiestl RH. Intestinal bacteria modify lymphoma incidence and latency by affecting systemic inflammatory state, oxidative stress, and leucocyte genotoxicity. Cancer Research. 2013 Jul 15;73(14):4222-4232.
- McHardy IH, Goudarzi M, Tong M, Ruegger PM, Schwager E, Weger JR, Graeber TG, Sonnenburg JL, Horvath S, Huttenhower C, McGovern DP, Fornace AJ, Jr., Borneman J, Braun J. Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships. Microbiome. 2013;1:17.
- Fu J, Wei B, Wen T, Johansson ME, Liu X, Bradford E, Thomsson KA, McGee S, Mansour L, Tong M, McDaniel JM, Sferra TJ, Turner JR, Chen H, Hansson GC, Braun J, Xia L. Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J Clin Invest. 2011;121:1657-1666.